Get started
Author

Femi Williams Adeoye

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 354
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2023 · Obbina Abani, Ali Abbas, et al. · The Lancet · 141
Durvalumab-induced triple-M syndrome
2024 · Femi Williams Adeoye, Nida Jaffar, et al. · European Journal of Case Reports in Internal Medicine · 6
PDF
Early-Onset Autoimmune Hemolytic Anemia from Pembrolizumab in a Patient with Metastatic Lung Cancer: A Case Report
2025 · Femi Williams Adeoye, Sanggeeta Surandran, et al. · American Journal of Case Reports · 4
Prophylactic cranial irradiation in small cell lung cancer: A review of evidence
2024 · Femi Williams Adeoye · Journal of Biomedical Research · 1
PDF
The Use of Combination Palliative Radiotherapy and Single‐Agent Immunotherapy for the Management of Head and Neck Squamous Cell Carcinoma ( HNSCC ) in the United Kingdom ( UK )
2026 · Chris Hurt, Sarah Park, et al. · International Journal of Cancer
PDF
High-dose-rate brachytherapy boost with external beam radiotherapy for localized prostate cancer: Long-term outcomes and toxicity in 607 predominantly high-risk patients
2026 · Mahbuba Choudhury, Femi Adeoye, et al. · Brachytherapy
104 Prophylactic cranial irradiation versus active surveillance in limited-stage small cell lung cancer: a 10-year retrospective analysis
2026 · Mahbuba Choudhury, Femi Williams Adeoye, et al. · Radiotherapy and Oncology
The use of combination palliative radiotherapy and single agent immunotherapy for the management of head and neck squamous carcinoma (HNSCC) in the UK
2026 · Chris Hurt, Sarah Park, et al. · Radiotherapy and Oncology
262 Long-term survival outcomes of prophylactic cranial irradiation versus active surveillance following thoracic chemoradiotherapy in Limited-stage Small-cell Lung Cancer: A decade of experience at a large centre in the UK
2026 · Femi Adeoye, Mahbuba Choudhury, et al. · Lung Cancer
The Landscape of Second Line (and Beyond) Treatments for Glioblastoma (idh Wildtype) in the Uk in 2021: an Update From the Histo-mol Gbm Collaborative
2025 · Stephen Robinson, Sean Farrell, et al. · Neuro-Oncology
PDF
High Dose Rate Brachytherapy Boost in Intermediate and High Risk Localized Prostate Cancer: A Retrospective Study on Toxicity and Clinical Outcomes
2025 · M. Choudhury, F. Adeoye, et al. · International Journal of Radiation Oncology*Biology*Physics
2802 Multi-centre real-world experience with adjuvant durvalumab after chemoradiotherapy in Non-small Cell Lung Cancer: five-year real-world outcomes
2025 · Femi Adeoye, Nida Jaffar, et al. · Radiotherapy and Oncology
81 Multicentre real-world experience with consolidation durvalumab after chemoradiotherapy in Non-small Cell Lung Cancer: A Five-year Retrospective Study
2025 · Femi Adeoye, Nida Jaffar, et al. · Lung Cancer
Prognosis Disclosure in Oncological Medicine
2024 · Femi Williams Adeoye · Journal of Clinical Case Studies Reviews & Reports
PDF
Works count: 15
Citation count: 503
H-index: 4
I10-index: 2
Year
Topic
Type